The document is a regulatory disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimating the schedule of an Analyst/Institutional Investor meeting.
The event is a one-to-one, in-person meeting with UTI Mutual Fund.
The meeting is scheduled for September 30, 2026, from 11:30 am to 12:30 pm.
The stated purpose of the meeting is not explicitly detailed beyond being an interaction with an institutional investor.
The company has explicitly stated that no unpublished price sensitive information (UPSI) is proposed to be shared during the meeting.
A note clarifies that the schedule may undergo changes due to exigencies on the part of the meeting participants or the Company.
The disclosure was signed by Kaleeswaran Arunachalam, Chief Financial Officer.
Additional Notes Section
The disclosure is a formal letter addressed to BSE Limited and the National Stock Exchange of India Limited, with the company reference number 88/2026-27.
No financial data, presentation decks, transcripts, or recordings were mentioned as being made available or attached to this intimation.
No other management participants were listed besides the CFO who signed the letter.
